Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Narcolepsy Drugs Market Outlook

The global narcolepsy drugs market reached a value of nearly USD 3.63 billion in 2023 and is further projected to achieve USD 8.85 billion by 2032, recording a CAGR of 10.4% over the forecast period of 2024-2032.

Narcolepsy Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The industry is being driven by the rapidly advancing technology, increased investment in the R&D sector by leading pharmaceutical companies, and the rising awareness regarding narcolepsy and its treatment among people.

Market Segmentation

Narcolepsy refers to a sleep disorder that causes excessive daytime drowsiness and is characterised by sleep paralysis and hallucinations, among other factors. It is a neurological disorder involving a reduced capacity to control sleep and wake cycles. The global narcolepsy drugs market can be segmented into disease type and therapeutic type.

Narcolepsy Drugs Market By Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The industry can be divided based on its disease types into daytime extreme sleepiness and cataplexia, among others. The industry is broadly categorised based on its therapeutic types into:

  • Central Nervous System Stimulants
  • Tricyclic Antidepressants
  • Sodium Oxybate
  • Selective Serotonin Reuptake Inhibitor
  • Others

The EMR report looks into the regional narcolepsy drugs markets like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

Market Analysis

The increased prevalence of narcolepsy, awareness regarding sleep disorders due to narcolepsy awareness programmes and camps, and the growing presence of reimbursement policies are the major factors that are accelerating the growth of the global narcolepsy drugs market. Further, the rising disposable incomes and increased expenditure in the health care sector by the governments, particularly in the developing nations, is expected to aid the global narcolepsy drugs market over the forecast period. The adverse effects related to narcolepsy drugs, along with the chances of delayed diagnosis or misdiagnosis, are the major drawbacks, which may affect the industry growth in the forecast period.

Narcolepsy Drugs Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

The report presents a detailed analysis of the following key players in the global narcolepsy drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Arena Pharmaceutical, Inc.
  • Jazz Pharmaceutical Plc
  • Bioprojet Pharma Sarl
  • Ligand Pharmaceuticals Incorporated
  • Shinogi Inc.
  • Takeda Pharmaceutical Company
  • Teva Pharmaceutical Industries Ltd.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Class
  • Disease Type
  • Dosage Form
  • Route of Administration
  • Population Type
  • End User
  • Treatment Channel
  • Distribution Channel
  • Region
Breakup by Drug Class
  • Selective Histamine H3-Receptor Antagonist
  • Stimulants
  • Serotonin Reuptake Inhibitors (SSRIs)
  • Tricyclic Antidepressants
  • Central Nervous System Depressant
  • Others
Breakup by Disease Type
  • Narcolepsy with Cataplexy
  • Narcolepsy without Cataplexy
  • Secondary Narcolepsy
Breakup by Dosage Form
  • Tablet
  • Capsule
  • Injectables
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
Breakup by Population Type
  • Childrens
  • Adults
  • Geriatrics
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others
Breakup by Treatment Channel
  • Public
  • Private
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Avadell
  • Vallon Pharmaceuticals
  • Jazz Pharmaceuticals, Inc.
  • Jubilant Pharmova Limited
  • BIOPROJET
  • Hikma Pharmaceuticals PLC
  • Amneal Pharmaceuticals LLC
  • Teva Pharmaceutical Industries Ltd.
  • Ligand Pharmaceuticals Incorporated
  • Novartis AG
  • Mylan N.V.
  • Alkem Labs
  • Alembic Pharmaceuticals Limited
  • Torrent Pharmaceuticals Ltd.
  • Johnson & Johnson 
  • F. Hoffmann-La Roche Ltd.
  • Zydus Cadila
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

In 2020, the global narcolepsy drugs market attained a value of about USD 3.63 billion in 2023.

The market is projected to grow at a CAGR of 10.4% between 2024 and 2032.

The market is being driven by the rising awareness regarding narcolepsy and its treatment methods, technological advancements, and the increasing research and development (R&D) activities.

The market growth is anticipated to be defined by the rising disposable incomes, the increasing expenditure in the healthcare sector, and the introduction of favourable governmental initiatives to enhance the accessibility of narcolepsy drugs.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major disease types of narcolepsy drugs include daytime extreme sleepiness and cataplexia, among others.

The significant therapeutic types of narcolepsy drugs are central nervous system stimulants, tricyclic antidepressants, sodium oxybate, and selective serotonin reuptake inhibitor, among others.

The major players in the industry are Arena Pharmaceutical, Inc., Jazz Pharmaceutical Plc, Bioprojet Pharma Sarl, Ligand Pharmaceuticals Incorporated, Shinogi Inc., Takeda Pharmaceutical Company, and Teva Pharmaceutical Industries Ltd., among others.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-120-433-0800

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124